Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Limited Competition for the Continuation of the Caring for…

U.S. National Institutes of Health·United States of America

Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)

Closes in 5 days$500k – $700kGrants Notice
Get bids like this by emailBid source

Description

This limited‑competition Notice of Funding Opportunity (NOFO) invites the current COPE‑AKI clinical trial consortium sites to apply for a three‑year extension of the U01 cooperative‑agreement clinical centers and the associated scientific/data research center. The award will fund continued patient enrollment, long‑term follow‑up, data management, analysis, and dissemination of findings aimed at establishing a standard of care for survivors of stage 2‑3 acute kidney injury. Successful applicants will manage multi‑site clinical operations, coordinate with the NIDDK Data and Sample Biorepository, and comply with NIH data‑sharing and reporting requirements. • 3‑year U01 cooperative agreement for up to three Clinical Centers and one Scientific/Data Research Center • Estimated total funding ≈ $1.85 M (≈ $600 k per award) • Must be a current recipient of the original COPE‑AKI award (RFA‑DK‑20‑011) • Responsibilities include patient recruitment, protocol implementation, data collection, interim reporting, and final analysis • Requires a Data Management & Sharing Plan, annual RPPRs, and adherence to NIH grant policy

Attached files

Contact

Ivonne Schulman

[email protected]

(301) 435-3350

Key dates

Opened
9/30/2025
Closes
11/6/2026
Projected award
1/1/2027
Duration
3 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
RFA-DK-27-125

Budget estimate

$500,000 – $700,000

The NOFO lists an estimated total funding of $1,850,000 for three awards, implying an average award size of roughly $600,000. Because the award is a three‑year cooperative agreement, the annual budget per award would be about $200,000, but actual amounts may vary based on the scope of each Clinical Center’s enrollment targets and data‑analysis responsibilities. Therefore, a reasonable expected budget range for a single award is $500,000 to $700,000 over the three‑year period.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 95%

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

Closes 11/9/2026Opened 9/3/2025

U.S. National Institutes of Health·United States of America

87% match

Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

Closes 11/5/2027Opened 10/28/2024

U.S. National Institutes of Health·United States of America

84% match

Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)

Closes 11/5/2029Opened 9/29/2025

U.S. National Institutes of Health·United States of America

83% match

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Closes 1/7/2028Opened 4/1/2021

U.S. National Institutes of Health·United States of America

82% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026

U.S. National Institutes of Health·United States of America

82% match

Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)

Closes 5/26/2028Opened 12/10/2025

U.S. National Institutes of Health·United States of America

82% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

81% match

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Closes 7/5/2029Opened 6/27/2025

U.S. National Institutes of Health·United States of America

81% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

81% match

Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

Closes 11/7/2028Opened 7/18/2025

U.S. National Institutes of Health·United States of America

81% match

Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

Closes 1/7/2028Opened 9/12/2022

U.S. National Institutes of Health·United States of America

81% match

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023

U.S. National Institutes of Health·United States of America

81% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. National Institutes of Health·United States of America

81% match

Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)

Closes 11/16/2029Opened 7/8/2025

U.S. National Institutes of Health·United States of America

80% match

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

Closes 3/9/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

80% match

NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional)

Closes 1/27/2027Opened 7/1/2026

U.S. National Institutes of Health·United States of America

80% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

80% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

80% match

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

80% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

80% match

Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Closes 2/15/2027Opened 7/1/2026

U.S. National Institutes of Health·United States of America

80% match

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Closes 11/2/2028Opened 5/9/2025

U.S. National Institutes of Health·United States of America

80% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

80% match

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

Closes 11/15/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

80% match

KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 7/1/2026